Anesthetic management of patients undergoing coronary artery bypass grafting with the use of an axial flow pump and a short-acting β-blocker

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 4, 1999, Pages 431-436

  Peterzén, Bengt ^a,b   Lönn, Urban ^a   Babi'c, Ankica ^a   Carnstam, Bo ^a   Rutberg, Hans ^a   Casimir Ahn, Henrik ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Axial flow pump; Beating heart surgery; Coronary artery bypass grafting; blocker

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INOTROPIC AGENT; TROPONIN T;

ADULT; AGED; ARTERY CATHETER; ARTICLE; ASCENDING AORTA; BLOOD PUMP; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART MOVEMENT; HEART RATE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEMODYNAMIC MONITORING; HUMAN; MALE; MEAN ARTERIAL PRESSURE; OXYGEN SATURATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY ARTERY;

EID: 0032816743     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90215-X     Document Type: Article

References (21)

1. Kirklin JK: Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 51:529-531, 1991
2. Bufflo EA, Andrade JCS, Branco JNR, et al: Myocardial revascularization without extracorporeal circulation: Seven years experience in 593 cases. Eur J Cardiothorac Surg 4:504-508, 1990
3. Benetti FJ, Naselli G, Wood M, Geffner L: Direct myocardial revascularization without extracorporeal circulation: Experience in 700 patients. Chest 100:312-316, 1991
4. Pfister AJ, Zaki MS, Garcia JM, et al: Coronary artery bypass without cardiopulmonary bypass. Ann Thorac Surg 54:1085-1092, 1992
5. Lönn U, Peterzén B, Granfeldt H, Casimir-Ahn H: Coronary artery operation supported by the Hemopump: An experimental study on pig. Ann Thorac Surg 58:516-518, 1994
6. Lönn U, Peterzén B, Granfeldt H, Casimir-Ahn H: Coronary artery operation with support of the Hemopump cardiac assist system. Ann Thorac Surg 58:519-523, 1994
7. Borst C, Santamore WP, Smedira NG, Bredée JJ: Minimally invasive coronary artery bypass grafting: On the beating heart and via limited access. Ann Thorac Surg 63:S1-S5, 1997
8. Higgins TL, Estafanous FG, Loop FD, et al: Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: A clinical severity score. JAMA 267:2344-2348, 1992
9. Hoffman JBE, Buckberg GD: Transmural variation in myocardial perfusion, In Yu PN, Goodwin JF (eds): Progress in Cardiology. Philadelphia, PA, Lea & Febiger, 1976, pp 37-89
10. Sidi A, Rush W: Decreased regional lactate production and output due to intracoronary continuous infusion of esmolol during artery occlusion in dogs. J Cardiovasc Thorac Anesth 5:237-242, 1991
11. Nayler WG, Fassold E, Yepez C: Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone. Cardiovasc Res 12:152-161, 1978
12. Booth JV, McRace RL, Chesnut LC, et al: Acute myocardial β-adrenergic receptor desensitization in canine model during CPB: Mechanisms and therapeutic intervention. Anesth Analg 84:SCA1, 1997
13. Röth E, Török B: Effect of the ultra-short-acting β-blocker Brevibloc on free-radical mediated injuries during early reperfusion state. Basic Res Cardiol 86:422-433, 1991
14. Cork RC, Kramer TH, Dreischmeier B, et al: The effect of esmolol given during cardiopulmonary bypass. Anesth Analg 80:28-40, 1995
15. Cork RC, Azari DM, McQueen KAK, et al: Effect of esmolol given during cardiopulmonary bypass on fractional area of contraction from transesophageal echocardiography. Anesth Analg 81:219-224, 1995
16. The Esmolol Research Group: Intravenous esmolol for treatment of supraventricular tachyarrhythmia: Results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. Am Heart J 112:498-505,1986
17. Persson L, Hårdemark H-G, Gustavsson J, et al: S100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke 18:911-918, 1987
18. Westaby S, Johnsson P, Parry AJ, et al: Serum S100 protein: A potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg 61:88-92, 1996
19. Lachmann B: Open up the lung and keep the lung open. Int Care Med 18:319-321, 1992
20. Joachimsson P-O, Sjöberg F, Forsman M, et al: Adverse effects of hyperoxemia during cardiopulmonary bypass. J Thorac Cardiovasc Surg 112:812-819, 1996
21. Frank SM, Beattie C, Christopherson R, et al: Unintentional hypothermia is associated with postoperative myocardial ischemia. Anesthesiology 78:468-476, 1993